Glutathione in dermatology: a bright future or fading hype
Ghrelin: much more than a hunger hormone
Omega-3 Food Fact Sheet British Dietetic Association
Mounjaro, another brand name for semaglutide, has gained recognition as a valuable medication for managing type 2 diabetes
Overall, a majority (62%) of adults say it is either not too or not at all likely that the Trump administrations policies will lower prescription drug costs for people like them, while about four in ten (38%) say they think it is very or somewhat likely. These expectations are largely driven by partisanship, with large majorities of Republicans (73%) and MAGA-supporting Republican and Republican leaning independents (83%) saying it is likely the administration will lower drug costs for people like them
States with no obesity GLP-1 coverage: Most remaining states including Texas, Florida, Ohio, New Jersey, and Georgia do not cover GLP-1s for obesity at all